Drug Database
Back to search

Netherlands· NL-4223e932f265

Octreotide depot Teva 10 mg, poeder en oplosmiddel voor suspensie voor injectie met verlengde afgifte

A octreotide product containing octreotideacetaat, registered in Netherlands by Teva B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC H01CB02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedOctreotide depot Teva 10 mg, poeder e…ATCH01CB02REGISTER NO.NL-4223e932f265PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about octreotideacetaatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Octreotide is registered in 17 of 19 countries.

Countries holding a registration under ATC H01CB02 (octreotide), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose
Search octreotide products by name

Octreotide · ATC H01CB02

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of octreotide costs, country by country.

Normalised to the WHO defined daily dose (0.7 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Octreotide · price per daily dose (0.7 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$41.46
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
OCTREOTIDEACETAAT
Manufacturer
Teva B.V.
Country
Netherlands (NL)
ATC code
H01CB02
ATC class
Octreotide
Defined daily dose
0.7 mg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    122162

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

367 interactions on record for octreotide.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check octreotide against other medicinesHow interaction checks work

Octreotide · interactions on record

367 records

  • 4 severe
  • 151 moderate
  • 4 minor
  • 168 info

Most severe, free to view

  • LonafarnibA16AX20severe
  • PexidartinibL01EX15severe
  • BexaroteneL01XF03severe
  • BexarotenL01XX25severe

40 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Octreotide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All octreotide products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Octreotide Ratiopharm, Sandostatin
  • Belgium · Octreoteva Long Acting, Octreotide Qilu
  • Bulgaria · Octreotid Lyomark, Октреотид Lai Тева
  • Cyprus · Octreotide Rompharm, Sandostatin
  • Czechia · Octreotide Teva, Octreotide Teva B.V.
  • Germany · Octreo Ratiopharm, Octreotid Bendalis
  • Denmark · Octreoanne, Octreotid Sun
  • Estonia · Octreotide Teva, Sandostatin
  • Spain · Octreotida Gp-Pharm, Octreotida Sun
  • Finland · Octreotide Orion, Octreotide Ratiopharm
  • France · Octreotide Arrow, Octreotide Hospira
  • United Kingdom (Northern Ireland) · Octreotide Chemi, Octreotide Hospira Uk
  • Greece · Okrodin, Sandostatin
  • Croatia · Oktreotid Teva, Sandostatin
  • Hungary · Oktreotid Teva, Sandostatin
  • Ireland · Octreotide Pfizer Healthcare Ireland, Olatuton
  • Iceland · Octreoanne, Oczyesa
  • Italy · Octreotide Bioindustria L.I.M., Octreotide Sun
  • Liechtenstein · Oczyesa
  • Lithuania · Octreotide Teva, Sandostatin
  • Luxembourg · Octreoteva Long Acting, Sandostatine
  • Latvia · Sandostatin, Sandostatin Lar
  • Malta · Sandostatin, Sandostatin Lar
  • Norway · Octreoanne, Octreotide Orion
  • Poland · Okteva, Sandostatin
  • Portugal · Octreotido Color, Octreotido Depot Teva
  • Romania · Octreotidă Rompharm, Octreotidă Teva
  • Sweden · Octreotide Orion, Octreotide Teva
  • Slovenia · Oktreotid Teva, Sandostatin
  • Slovakia · Sandostatin, Sandostatin Lar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/016a6a89-c725-43e8-bd9d-6c00b8a39696
GET /v1/drugs/016a6a89-c725-43e8-bd9d-6c00b8a39696?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder en oplosmiddel voor suspensie voor injectie",
  "route": "Intramusculair gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h122162_smpc.pdf",
  "strength": null,
  "atc_label": "Octreotide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg122162",
  "excipients": [
    "CARMELLOSE NATRIUM (E 466)",
    "MANNITOL (D-) (E 421)",
    "MANNITOL (D-) (E 421)",
    "MELKZUUR(D,L)-GLYCOLZUUR COPOLYMEER",
    "POLOXAMEER 188",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "OCTREOTIDEACETAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h122162.pdf",
  "authorised_at": "2019/08/07",
  "procedure_number": "CZ/H/0801/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "122162",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about octreotide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console